Why the study?
Nitric oxide synthesis is impaired and its degradation accelerated in conditions associated with atherosclerosis, motivating strategies to restore endothelial function and vessel integrity.
Highlights the critical gap between evidence-based guidelines and actual clinical practice in prescribing proven cardiovascular therapies, emphasizing the need for improved educational programs.
Persistent underuse of proven therapies warrants implementation research; leaves open which strategies most effectively close the evidence-practice gap.
The endothelium is a diaphanous membrane, only one cell layer thick, that lines all of our blood vessels. Despite its apparent fragility, it exerts profound control over vascular tone, structure, and interaction with circulating blood elements. One of the factors that the endothelium synthesizes is nitric oxide, which is the most potent endogenous vasodilator known. In addition to its blood flow regulating effects, nitric oxide also inhibits key processes in atherosclerosis, including monocyte adherence, platelet aggregation, and proliferation of vascular smooth muscle cells. Nitric oxide synthesis is impaired, and its degradation is accelerated, in many of the conditions associated with atherosclerosis, including hypercholesterolemia. Restoration of nitric oxide synthesis and activity in these disorders can improve blood flow, relieve symptoms, and perhaps reduce the progression of atherosclerosis.
No takes yet. Share an insight, caveat, or question.
Lissin et al. (2000) conducted a review in Atherosclerosis. Restoration of nitric oxide synthesis and activity was evaluated.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: